ANTGX
Price
$11.10
Change
-$0.00 (-0.00%)
Updated
Jun 2 closing price
Net Assets
551.01M
TRTIX
Price
$26.28
Change
+$0.15 (+0.57%)
Updated
Jun 2 closing price
Net Assets
17.12B
Interact to see
Advertisement

ANTGX vs TRTIX

Header iconANTGX vs TRTIX Comparison
Open Charts ANTGX vs TRTIXBanner chart's image
ANTGX vs TRTIX Comparison Chart in %
View a ticker or compare two or three
VS
ANTGX vs. TRTIX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANTGX is a Hold and TRTIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TRTIX has more cash in the bank: 17.1B vs. ANTGX (551M). ANTGX pays higher dividends than TRTIX: ANTGX (4.60) vs TRTIX (2.52). ANTGX was incepted earlier than TRTIX: ANTGX (7 years) vs TRTIX (11 years). ANTGX (0.83) is less costly to investors than TRTIX (0.68). ANTGX is a more actively managed with annual turnover of: 71.00 vs. TRTIX (15.00). ANTGX has a lower initial minimum investment than TRTIX: ANTGX (0) vs TRTIX (500000). TRTIX annual gain was more profitable for investors over the last year : 29.56 vs. ANTGX (18.40). TRTIX return over 5 years is better than : 84.98 vs. ANTGX (25.04).
ANTGXTRTIXANTGX / TRTIX
Total Expense Ratio0.030.684%
Annual Report Gross Expense Ratio0.830.68122%
Fund Existence7 years11 years-
Gain YTD7.87211.05071%
Front LoadN/AN/A-
Min. Initial Investment0500000-
Min. Initial Investment IRAN/AN/A-
Net Assets551M17.1B3%
Annual Yield % from dividends4.602.52183%
Returns for 1 year18.4029.5662%
Returns for 3 years28.4989.1332%
Returns for 5 years25.0484.9829%
Returns for 10 yearsN/A151.13-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATEX66.961.60
+2.45%
Anterix
FRAF56.63-0.39
-0.68%
Franklin Financial Services Corp
MNST88.24-0.86
-0.97%
Monster Beverage Corp
TFX125.24-2.33
-1.83%
Teleflex
VTGN0.58-0.07
-10.42%
VistaGen Therapeutics